Marie-Mélanie Dauplat

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Jean‐Marc Nabholtz, Catherine Abrial, Marie‐Ange Mouret‐Reynier et al. · Annals of Oncology · 2014 · 122 citations

Breast Oncology, Medicine, Treatment Impact +8

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Marie Béguinot, Marie-Mélanie Dauplat, Fabrice Kwiatkowski et al. · BMC Cancer · 2018 · 47 citations · Full text

<i>TERT</i> promoter status and gene copy number gains: effect on <i>TERT</i> expression and association with prognosis in breast cancer

Mathilde Gay‐Bellile, Lauren Véronèse, Patricia Combes et al. · Oncotarget · 2017 · 44 citations · Full text

Ovarian epithelial dysplasia after ovulation induction: time and dose effects

Geneviève Chêne, Frédérique Penault‐Llorca, G. Le Bouëdec et al. · Human Reproduction · 2008 · 35 citations · Full text

Ovarian Epithelial Dysplasia and Prophylactic Oophorectomy for Genetic Risk

Frédérique Penault‐Llorca, G. Le Bouëdec, Florence Mishellany et al. · International Journal of Gynecological Cancer · 2009 · 30 citations